Do you routinely monitor INR when starting GLP1 R agonist therapy on patients taking warfarin?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

Do you avoid the use of GLP-1 R agonist therapy for treatment of obesity in patients with known gastroparesis?

For atrial fibrillation patients with high risk of CVA who cannot tolerate full dose AC due to bleeding, do you consider low dose/extended dosing anticoagulation even if they do not meet age/GFR criteria for a dose reduction, if Watchman is not readily available as an option?

What specific side effects would prompt you to stop teplizumab (TZIELD) therapy in patients aiming to delay the onset of stage 3 type 1 diabetes mellitus?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.